Clinical Trials Logo

Clinical Trial Summary

Hypernatremia is frequently encountered in patients admitted to the Intensive Care Unit (ICU) and associated with increased mortality and length of stay. Previous studies focused on predictors in the development and recovery of hypernatremia by including amount and types of administered medication, fluid balance, laboratory results and changes in vital signs. However, data of larger populations or data on infusion rates, fluid and salt balance or renal replacement therapy is lacking. This study aims to provide better insight in the development and recovery of hypernatremia through the collection of detailed information on the input and output of fluids and salts in a larger group of patients than studied before.


Clinical Trial Description

Hypernatremia is frequently encountered in patients admitted to the Intensive Care Unit (ICU) and associated with increased mortality and length of stay. The main mechanism is an imbalance between sodium and total body water. Consequently, this poses multiple factors to play a role in the development of hypernatremia. multifactorial. Previous studies focused on predictors in the development of hypernatremia by including amount and types of administered medication, fluid balance, laboratory results and changes in vital signs. However, data of larger populations or data on infusion rates, fluid and salt balance or renal replacement therapy is lacking. Few studies investigated the recovery of hypernatremia, which showed that correction of hypernatremia can reduce the associated mortality risk.

This study aims to provide better insight in the development and recovery of hypernatremia through the collection of detailed information on the input and output of fluids and salts in a larger group of patients than studied before. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03752450
Study type Observational
Source Catharina Ziekenhuis Eindhoven
Contact
Status Completed
Phase
Start date May 25, 2018
Completion date April 10, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06037928 - Plasma Sodium and Sodium Administration in the ICU
Completed NCT02926989 - Intravenous Fluids in Hospitalised Children Phase 4
Not yet recruiting NCT05085223 - Prospective Analysis Into Development of Hypernatremia in Critically Ill Patients
Withdrawn NCT01326429 - Frequency and Origin of Dysnatremias in the Emergency Department N/A
Completed NCT01456533 - Copeptin in the Differential Diagnosis of Dysnatremia in Hospitalized Patients N/A
Recruiting NCT03658850 - Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients Phase 2
Not yet recruiting NCT06061783 - Correction of Hypernatremia by Intravenous Hypotonic Solution Compared to Enteral Water N/A
Completed NCT02912299 - Investigation on Differences in Skin Sodium Content Between Normal Subjects and ICU-patients N/A
Completed NCT01219179 - Use of Sterile Water Feeds for Treatment of Hypernatremia in Extremely Low Birth Weight Infants N/A
Recruiting NCT04949139 - Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia Phase 4
Completed NCT00734214 - Hypotonic Versus Isotonic Parenteral (HIP) Fluid Trial Phase 3
Recruiting NCT02449382 - Continuous Venovenous Hemofiltration Versus Conventional Treatment for Acute Severe Hypernatremia N/A
Withdrawn NCT01617798 - Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis N/A
Recruiting NCT05818826 - Early Versus Conventional Cessation of Hydrocortisone in Septic Shock Phase 2
Recruiting NCT01299428 - Evaluation of the Cerebral Oxygenation With Near Infrared Spectrophotometry (NIRS) at the Hypernatremic Dehydration in Newborn N/A
Recruiting NCT04265976 - ED Hypernatremia. Prognostic Factors and Epidemiology.
Completed NCT03610074 - Relieve the Patient's Thirst, Refresh the Mouth First (ICU-MIC) N/A